Related Experiment Video
Updated: Jul 29, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Immunotherapy in Anal Cancer.
Natasha Dhawan1, Muhammad Z Afzal1, Manik Amin1
1Department of Medical Oncology, Dartmouth Cancer Center, Lebanon, NH 03756, USA.
Immunotherapy is emerging as a key treatment for anal cancer, particularly squamous cell carcinoma. Research focuses on integrating immunotherapies like checkpoint inhibitors and vaccines into various treatment stages.
Area of Science:
- Oncology
- Immunology
- Virology
Background:
- Squamous cell carcinoma of the anus incidence and mortality are rising globally.
- High-risk human papilloma virus (HPV) infections are linked to most anal cancers.
- HPV oncoproteins E6 and E7 can elicit anti-tumor immune responses.
Purpose of the Study:
- To review the evolving role of immunotherapy in treating anal squamous cell carcinoma.
- To summarize current research and future directions for immunotherapy in anal cancer treatment.
Main Methods:
- Review of current literature on anal cancer treatment modalities.
- Analysis of the impact of human papilloma virus (HPV) on anti-tumor immunity.
- Exploration of various immunotherapy strategies under investigation.
Main Results:
- Immunotherapy, including immune checkpoint inhibitors, adoptive cell therapy, and vaccines, shows promise for anal cancer.
- Combination therapies incorporating immunomodulating non-immunotherapies are being explored.
- Research is actively investigating immunotherapy sequencing for different stages of anal cancer.
Conclusions:
- Immunotherapy represents a significant advancement in the treatment paradigm for anal cancer.
- Further research is crucial to optimize the use of immunotherapy in both locally advanced and metastatic settings.
- Integrating immunotherapy strategies holds potential for improved patient outcomes in anal squamous cell carcinoma.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

